

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.61183361 |
| 2 | muscle filament sliding (GO:0030049) | 6.61183361 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.71274229 |
| 4 | actin-mediated cell contraction (GO:0070252) | 5.57981061 |
| 5 | skeletal muscle contraction (GO:0003009) | 5.33023595 |
| 6 | sarcomere organization (GO:0045214) | 4.88921925 |
| 7 | regulation of relaxation of muscle (GO:1901077) | 4.78749155 |
| 8 | actin filament-based movement (GO:0030048) | 4.72734158 |
| 9 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.32587615 |
| 10 | skeletal muscle adaptation (GO:0043501) | 4.31716841 |
| 11 | myofibril assembly (GO:0030239) | 4.17653822 |
| 12 | cellular extravasation (GO:0045123) | 4.07216311 |
| 13 | striated muscle contraction (GO:0006941) | 4.05286826 |
| 14 | negative regulation of necroptotic process (GO:0060546) | 4.01344178 |
| 15 | nuclear pore complex assembly (GO:0051292) | 3.90987396 |
| 16 | regulation of necroptotic process (GO:0060544) | 3.88464960 |
| 17 | endoplasmic reticulum organization (GO:0007029) | 3.87107642 |
| 18 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.85766986 |
| 19 | N-terminal protein amino acid acetylation (GO:0006474) | 3.81209961 |
| 20 | COPI coating of Golgi vesicle (GO:0048205) | 3.74799973 |
| 21 | Golgi transport vesicle coating (GO:0048200) | 3.74799973 |
| 22 | fibroblast migration (GO:0010761) | 3.70888326 |
| 23 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.60838733 |
| 24 | actomyosin structure organization (GO:0031032) | 3.47842101 |
| 25 | cardiac myofibril assembly (GO:0055003) | 3.46721774 |
| 26 | COPII vesicle coating (GO:0048208) | 3.45830546 |
| 27 | motile cilium assembly (GO:0044458) | 3.44163209 |
| 28 | regulation of skeletal muscle contraction (GO:0014819) | 3.44101120 |
| 29 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.41378881 |
| 30 | striated muscle atrophy (GO:0014891) | 3.41353966 |
| 31 | response to inactivity (GO:0014854) | 3.41093258 |
| 32 | response to muscle activity (GO:0014850) | 3.39513445 |
| 33 | positive regulation of myotube differentiation (GO:0010831) | 3.39224503 |
| 34 | cardiac muscle hypertrophy (GO:0003300) | 3.37825818 |
| 35 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.34223407 |
| 36 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.32377409 |
| 37 | cardiac muscle contraction (GO:0060048) | 3.32061503 |
| 38 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.23046820 |
| 39 | striated muscle hypertrophy (GO:0014897) | 3.20582022 |
| 40 | striated muscle adaptation (GO:0014888) | 3.20345260 |
| 41 | succinate metabolic process (GO:0006105) | 3.20184136 |
| 42 | response to epinephrine (GO:0071871) | 3.17642007 |
| 43 | regulation of actin filament-based movement (GO:1903115) | 3.13442119 |
| 44 | histone H3-K36 demethylation (GO:0070544) | 3.12016973 |
| 45 | glycogen catabolic process (GO:0005980) | 3.11437483 |
| 46 | regulation of cell communication by electrical coupling (GO:0010649) | 3.09401519 |
| 47 | negative regulation of necrotic cell death (GO:0060547) | 3.09170554 |
| 48 | glucan catabolic process (GO:0009251) | 3.02349211 |
| 49 | vesicle transport along microtubule (GO:0047496) | 2.99035778 |
| 50 | muscle cell cellular homeostasis (GO:0046716) | 2.98596387 |
| 51 | nuclear pore organization (GO:0006999) | 2.98409893 |
| 52 | coronary vasculature morphogenesis (GO:0060977) | 2.95958781 |
| 53 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.95212066 |
| 54 | carnitine shuttle (GO:0006853) | 2.92500584 |
| 55 | cellular polysaccharide catabolic process (GO:0044247) | 2.91640657 |
| 56 | vesicle coating (GO:0006901) | 2.91224938 |
| 57 | muscle atrophy (GO:0014889) | 2.90448491 |
| 58 | protein targeting to Golgi (GO:0000042) | 2.85309198 |
| 59 | mitochondrion distribution (GO:0048311) | 2.84389224 |
| 60 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.84330399 |
| 61 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.83344266 |
| 62 | pore complex assembly (GO:0046931) | 2.81901372 |
| 63 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.81060445 |
| 64 | dosage compensation (GO:0007549) | 2.78472532 |
| 65 | muscle contraction (GO:0006936) | 2.76248279 |
| 66 | establishment of protein localization to Golgi (GO:0072600) | 2.76109956 |
| 67 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.75222953 |
| 68 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.72850064 |
| 69 | germinal center formation (GO:0002467) | 2.72459835 |
| 70 | positive regulation of developmental pigmentation (GO:0048087) | 2.70485314 |
| 71 | DNA methylation involved in gamete generation (GO:0043046) | 2.68139534 |
| 72 | muscle hypertrophy (GO:0014896) | 2.67508831 |
| 73 | regulation of pigment cell differentiation (GO:0050932) | 2.67390547 |
| 74 | skeletal muscle tissue development (GO:0007519) | 2.66646363 |
| 75 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.65919096 |
| 76 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.63096128 |
| 77 | peptidyl-lysine dimethylation (GO:0018027) | 2.62780105 |
| 78 | negative regulation of protein oligomerization (GO:0032460) | 2.61533141 |
| 79 | skeletal muscle fiber development (GO:0048741) | 2.60496702 |
| 80 | protein localization to Golgi apparatus (GO:0034067) | 2.58311588 |
| 81 | polysaccharide catabolic process (GO:0000272) | 2.53833960 |
| 82 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.53220436 |
| 83 | regulation of protein polyubiquitination (GO:1902914) | 2.51204873 |
| 84 | neutrophil mediated immunity (GO:0002446) | 2.50949283 |
| 85 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.50272390 |
| 86 | cellular response to epinephrine stimulus (GO:0071872) | 2.50258398 |
| 87 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.49875758 |
| 88 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.49419992 |
| 89 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.48263658 |
| 90 | negative regulation of cell killing (GO:0031342) | 2.47934591 |
| 91 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.47934591 |
| 92 | plasma membrane repair (GO:0001778) | 2.47865358 |
| 93 | cardiac muscle adaptation (GO:0014887) | 2.45816514 |
| 94 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.45816514 |
| 95 | muscle hypertrophy in response to stress (GO:0003299) | 2.45816514 |
| 96 | regulation of cofactor metabolic process (GO:0051193) | 2.45741989 |
| 97 | regulation of coenzyme metabolic process (GO:0051196) | 2.45741989 |
| 98 | histone H3-K9 demethylation (GO:0033169) | 2.45295274 |
| 99 | regulation of sequestering of triglyceride (GO:0010889) | 2.44894018 |
| 100 | response to laminar fluid shear stress (GO:0034616) | 2.44246894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 4.51654960 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.37200355 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.02879056 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.35146132 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.23237436 |
| 6 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.71635344 |
| 7 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.59074269 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.47558935 |
| 9 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.39617346 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.27073739 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19743257 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12089233 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02816917 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01531975 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.99390206 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.94189626 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91665967 |
| 18 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.90834511 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.90024505 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.89810658 |
| 21 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.89153098 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89104316 |
| 23 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.86062899 |
| 24 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.86062899 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81854733 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81401779 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.81171353 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77926604 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75140686 |
| 30 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.68613718 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59818132 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.59065348 |
| 33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.56997759 |
| 34 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.51860895 |
| 35 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.49519541 |
| 36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48852010 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47939456 |
| 38 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.47263141 |
| 39 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.47263141 |
| 40 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.45211752 |
| 41 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.43446385 |
| 42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.41875520 |
| 43 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.41298008 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40581860 |
| 45 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.39309451 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37227219 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.33935934 |
| 48 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.32568388 |
| 49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27314597 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27314597 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27082779 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26976296 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26240204 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26149064 |
| 55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.25682653 |
| 56 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.25540114 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24425411 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.24396475 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23183207 |
| 60 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22652913 |
| 61 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.22627788 |
| 62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.21418898 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19397841 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17127728 |
| 65 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16693417 |
| 66 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16165926 |
| 67 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14591838 |
| 68 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.13789255 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13439375 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12971265 |
| 71 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.12733308 |
| 72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12406977 |
| 73 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.11991277 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11463507 |
| 75 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11403439 |
| 76 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10350253 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08699913 |
| 78 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.08610617 |
| 79 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07789330 |
| 80 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.06511983 |
| 81 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.06088145 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.04014650 |
| 83 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03277200 |
| 84 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.02215931 |
| 85 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01775842 |
| 86 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98834488 |
| 87 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98097675 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.98037137 |
| 89 | MYB_26560356_Chip-Seq_TH2_Human | 0.97952169 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96242336 |
| 91 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96156731 |
| 92 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96125809 |
| 93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95718935 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94229587 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.91144338 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91057563 |
| 97 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.89942699 |
| 98 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89042753 |
| 99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88978215 |
| 100 | STAT3_23295773_ChIP-Seq_U87_Human | 0.88580665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.66979829 |
| 2 | MP0000749_muscle_degeneration | 4.24197078 |
| 3 | MP0000751_myopathy | 4.07353913 |
| 4 | MP0004233_abnormal_muscle_weight | 4.02753715 |
| 5 | MP0005451_abnormal_body_composition | 3.74000648 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.38413797 |
| 7 | MP0002332_abnormal_exercise_endurance | 3.01148601 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 2.83133919 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.70056274 |
| 10 | MP0000747_muscle_weakness | 2.65591274 |
| 11 | MP0004130_abnormal_muscle_cell | 2.60490344 |
| 12 | MP0000759_abnormal_skeletal_muscle | 2.56023821 |
| 13 | MP0002009_preneoplasia | 2.51386561 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.50168771 |
| 15 | MP0002106_abnormal_muscle_physiology | 2.47818476 |
| 16 | MP0002269_muscular_atrophy | 2.43225734 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.39153325 |
| 18 | MP0000733_abnormal_muscle_development | 2.17673947 |
| 19 | MP0004484_altered_response_of | 2.15008730 |
| 20 | MP0005369_muscle_phenotype | 1.96951284 |
| 21 | MP0003221_abnormal_cardiomyocyte_apopto | 1.96179079 |
| 22 | MP0000750_abnormal_muscle_regeneration | 1.95343806 |
| 23 | MP0000013_abnormal_adipose_tissue | 1.92903917 |
| 24 | MP0005330_cardiomyopathy | 1.85991793 |
| 25 | MP0003828_pulmonary_edema | 1.81918172 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 1.80084426 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.65422805 |
| 28 | MP0005620_abnormal_muscle_contractility | 1.63797158 |
| 29 | MP0003045_fibrosis | 1.60015096 |
| 30 | MP0004510_myositis | 1.52600315 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.50984471 |
| 32 | MP0000569_abnormal_digit_pigmentation | 1.50683407 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.50438253 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.49708964 |
| 35 | MP0002822_catalepsy | 1.48510365 |
| 36 | MP0002971_abnormal_brown_adipose | 1.48195411 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.37967303 |
| 38 | MP0002972_abnormal_cardiac_muscle | 1.34506152 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.32888251 |
| 40 | MP0005248_abnormal_Harderian_gland | 1.28526022 |
| 41 | MP0010630_abnormal_cardiac_muscle | 1.27698200 |
| 42 | MP0005266_abnormal_metabolism | 1.26209223 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.25873027 |
| 44 | MP0000003_abnormal_adipose_tissue | 1.17659618 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 1.15135005 |
| 46 | MP0001727_abnormal_embryo_implantation | 1.14998369 |
| 47 | MP0001544_abnormal_cardiovascular_syste | 1.14160944 |
| 48 | MP0005385_cardiovascular_system_phenoty | 1.14160944 |
| 49 | MP0003763_abnormal_thymus_physiology | 1.13088900 |
| 50 | MP0003091_abnormal_cell_migration | 1.12125380 |
| 51 | MP0002108_abnormal_muscle_morphology | 1.11777679 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.11182736 |
| 53 | MP0005076_abnormal_cell_differentiation | 1.06827402 |
| 54 | MP0008260_abnormal_autophagy | 1.06117426 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.06097050 |
| 56 | MP0001661_extended_life_span | 1.01862774 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.01528487 |
| 58 | MP0005171_absent_coat_pigmentation | 0.99799238 |
| 59 | MP0002006_tumorigenesis | 0.98681146 |
| 60 | MP0003879_abnormal_hair_cell | 0.95737964 |
| 61 | MP0003724_increased_susceptibility_to | 0.89627900 |
| 62 | MP0005375_adipose_tissue_phenotype | 0.86354011 |
| 63 | MP0004215_abnormal_myocardial_fiber | 0.82289306 |
| 64 | MP0001851_eye_inflammation | 0.82131907 |
| 65 | MP0003868_abnormal_feces_composition | 0.78327084 |
| 66 | MP0009115_abnormal_fat_cell | 0.77986607 |
| 67 | MP0006138_congestive_heart_failure | 0.75422145 |
| 68 | MP0008775_abnormal_heart_ventricle | 0.74682321 |
| 69 | MP0004270_analgesia | 0.72224087 |
| 70 | MP0008057_abnormal_DNA_replication | 0.69774680 |
| 71 | MP0002127_abnormal_cardiovascular_syste | 0.69374751 |
| 72 | MP0003303_peritoneal_inflammation | 0.68986740 |
| 73 | MP0001915_intracranial_hemorrhage | 0.67664525 |
| 74 | MP0004381_abnormal_hair_follicle | 0.66202134 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 0.65414218 |
| 76 | MP0003385_abnormal_body_wall | 0.63118681 |
| 77 | MP0005621_abnormal_cell_physiology | 0.60478045 |
| 78 | MP0008874_decreased_physiological_sensi | 0.59562794 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.58615192 |
| 80 | MP0000427_abnormal_hair_cycle | 0.58255204 |
| 81 | MP0000767_abnormal_smooth_muscle | 0.54165584 |
| 82 | MP0005376_homeostasis/metabolism_phenot | 0.53148858 |
| 83 | MP0000703_abnormal_thymus_morphology | 0.52630135 |
| 84 | MP0000266_abnormal_heart_morphology | 0.52381697 |
| 85 | MP0005384_cellular_phenotype | 0.52251086 |
| 86 | MP0009703_decreased_birth_body | 0.51367170 |
| 87 | MP0005464_abnormal_platelet_physiology | 0.48905989 |
| 88 | MP0005058_abnormal_lysosome_morphology | 0.48883012 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 0.48808590 |
| 90 | MP0001958_emphysema | 0.48365740 |
| 91 | MP0010155_abnormal_intestine_physiology | 0.48149227 |
| 92 | MP0010678_abnormal_skin_adnexa | 0.47674416 |
| 93 | MP0002722_abnormal_immune_system | 0.47266347 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.46207496 |
| 95 | MP0009672_abnormal_birth_weight | 0.45937688 |
| 96 | MP0004197_abnormal_fetal_growth/weight/ | 0.45779521 |
| 97 | MP0001299_abnormal_eye_distance/ | 0.45501461 |
| 98 | MP0005165_increased_susceptibility_to | 0.45461089 |
| 99 | MP0002168_other_aberrant_phenotype | 0.44551507 |
| 100 | MP0003948_abnormal_gas_homeostasis | 0.43475292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.54560251 |
| 2 | Nemaline bodies (HP:0003798) | 7.46548597 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.40276066 |
| 4 | Exercise-induced myalgia (HP:0003738) | 5.66483583 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 5.34384173 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 5.11616362 |
| 7 | Difficulty running (HP:0009046) | 4.87355891 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.80092975 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.77724735 |
| 10 | EMG: myopathic abnormalities (HP:0003458) | 4.52337739 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 4.39432688 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 3.88406782 |
| 13 | Subaortic stenosis (HP:0001682) | 3.88146235 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.88146235 |
| 15 | Distal arthrogryposis (HP:0005684) | 3.80898763 |
| 16 | Myoglobinuria (HP:0002913) | 3.75109305 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.70087884 |
| 18 | Frequent falls (HP:0002359) | 3.67841301 |
| 19 | Rimmed vacuoles (HP:0003805) | 3.52791207 |
| 20 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.47309503 |
| 21 | Neck muscle weakness (HP:0000467) | 3.43905913 |
| 22 | Myopathic facies (HP:0002058) | 3.38755733 |
| 23 | Rhabdomyolysis (HP:0003201) | 3.34567304 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 3.19313284 |
| 25 | Calcaneovalgus deformity (HP:0001848) | 3.11379496 |
| 26 | Ulnar deviation of the wrist (HP:0003049) | 3.06915602 |
| 27 | Increased variability in muscle fiber diameter (HP:0003557) | 3.01740164 |
| 28 | Sudden death (HP:0001699) | 2.89662506 |
| 29 | Papillary thyroid carcinoma (HP:0002895) | 2.86237788 |
| 30 | Muscle fiber splitting (HP:0003555) | 2.84828329 |
| 31 | Insidious onset (HP:0003587) | 2.81020283 |
| 32 | Termporal pattern (HP:0011008) | 2.81020283 |
| 33 | Round ear (HP:0100830) | 2.78040025 |
| 34 | Scapular winging (HP:0003691) | 2.70606819 |
| 35 | Increased connective tissue (HP:0009025) | 2.65932495 |
| 36 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.64681342 |
| 37 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.64681342 |
| 38 | Deformed tarsal bones (HP:0008119) | 2.62417082 |
| 39 | Pelvic girdle muscle weakness (HP:0003749) | 2.61488374 |
| 40 | Distal lower limb muscle weakness (HP:0009053) | 2.58265577 |
| 41 | EMG: neuropathic changes (HP:0003445) | 2.57440869 |
| 42 | Papilledema (HP:0001085) | 2.50980511 |
| 43 | Bundle branch block (HP:0011710) | 2.49668007 |
| 44 | Distal lower limb amyotrophy (HP:0008944) | 2.46544118 |
| 45 | Abnormality of the foot musculature (HP:0001436) | 2.40464823 |
| 46 | Foot dorsiflexor weakness (HP:0009027) | 2.39861468 |
| 47 | Ventricular tachycardia (HP:0004756) | 2.38151015 |
| 48 | Limb-girdle muscle atrophy (HP:0003797) | 2.37366938 |
| 49 | Proximal amyotrophy (HP:0007126) | 2.34487864 |
| 50 | Malignant hyperthermia (HP:0002047) | 2.34101870 |
| 51 | Shoulder girdle muscle weakness (HP:0003547) | 2.32405352 |
| 52 | Areflexia of lower limbs (HP:0002522) | 2.31890168 |
| 53 | Fetal akinesia sequence (HP:0001989) | 2.28089358 |
| 54 | Dilated cardiomyopathy (HP:0001644) | 2.27387670 |
| 55 | Subacute progressive viral hepatitis (HP:0006572) | 2.23924598 |
| 56 | Popliteal pterygium (HP:0009756) | 2.19611193 |
| 57 | Muscle stiffness (HP:0003552) | 2.16677903 |
| 58 | Peritonitis (HP:0002586) | 2.15453216 |
| 59 | Abnormality of the calcaneus (HP:0008364) | 2.12930742 |
| 60 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.05712126 |
| 61 | Absent/shortened dynein arms (HP:0200106) | 2.05712126 |
| 62 | Spinal cord lesions (HP:0100561) | 2.02346637 |
| 63 | Syringomyelia (HP:0003396) | 2.02346637 |
| 64 | Fatigue (HP:0012378) | 2.01478638 |
| 65 | Limb-girdle muscle weakness (HP:0003325) | 2.00083101 |
| 66 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.99554617 |
| 67 | Generalized muscle weakness (HP:0003324) | 1.97662762 |
| 68 | Lipoatrophy (HP:0100578) | 1.93560166 |
| 69 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.90938581 |
| 70 | Weak cry (HP:0001612) | 1.87190681 |
| 71 | Metatarsus adductus (HP:0001840) | 1.87080121 |
| 72 | Heterotopia (HP:0002282) | 1.85551860 |
| 73 | Periodontitis (HP:0000704) | 1.85291289 |
| 74 | Muscular dystrophy (HP:0003560) | 1.83533344 |
| 75 | Bulbar palsy (HP:0001283) | 1.82196159 |
| 76 | Lower limb amyotrophy (HP:0007210) | 1.80966909 |
| 77 | Lower limb muscle weakness (HP:0007340) | 1.76740592 |
| 78 | Menstrual irregularities (HP:0000858) | 1.74640071 |
| 79 | Thyroid carcinoma (HP:0002890) | 1.74615026 |
| 80 | Gowers sign (HP:0003391) | 1.72060734 |
| 81 | Hyperkalemia (HP:0002153) | 1.69834250 |
| 82 | Brushfield spots (HP:0001088) | 1.68611015 |
| 83 | Urinary urgency (HP:0000012) | 1.67970901 |
| 84 | Resting tremor (HP:0002322) | 1.67350805 |
| 85 | Cortical dysplasia (HP:0002539) | 1.66535312 |
| 86 | Difficulty walking (HP:0002355) | 1.63753808 |
| 87 | Spinal rigidity (HP:0003306) | 1.63622054 |
| 88 | Cystic hygroma (HP:0000476) | 1.62507628 |
| 89 | Slender build (HP:0001533) | 1.61911304 |
| 90 | Pheochromocytoma (HP:0002666) | 1.58587904 |
| 91 | Long clavicles (HP:0000890) | 1.58169189 |
| 92 | Facial diplegia (HP:0001349) | 1.57641198 |
| 93 | Difficulty climbing stairs (HP:0003551) | 1.56015161 |
| 94 | Viral hepatitis (HP:0006562) | 1.55132001 |
| 95 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.54557722 |
| 96 | Progressive muscle weakness (HP:0003323) | 1.54111145 |
| 97 | Death in childhood (HP:0003819) | 1.54068440 |
| 98 | Right ventricular cardiomyopathy (HP:0011663) | 1.51255140 |
| 99 | Abnormality of the neuromuscular junction (HP:0003398) | 1.50415556 |
| 100 | Fatigable weakness (HP:0003473) | 1.50415556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.09948961 |
| 2 | TTN | 4.41618301 |
| 3 | LATS1 | 2.76225854 |
| 4 | STK38L | 2.40121590 |
| 5 | PHKG1 | 2.37465857 |
| 6 | PHKG2 | 2.37465857 |
| 7 | PIK3CG | 2.35027314 |
| 8 | EPHA3 | 2.04392308 |
| 9 | ERBB3 | 1.90498350 |
| 10 | MAP3K2 | 1.89934585 |
| 11 | PRPF4B | 1.79218105 |
| 12 | LATS2 | 1.78812957 |
| 13 | BRD4 | 1.61026523 |
| 14 | IRAK3 | 1.59237970 |
| 15 | STK38 | 1.57116794 |
| 16 | CCNB1 | 1.54114151 |
| 17 | KSR2 | 1.52257311 |
| 18 | JAK1 | 1.50664176 |
| 19 | AKT3 | 1.46174384 |
| 20 | NEK9 | 1.44915773 |
| 21 | SCYL2 | 1.42821334 |
| 22 | CAMKK2 | 1.41281658 |
| 23 | NEK1 | 1.40859399 |
| 24 | MAP3K4 | 1.40600419 |
| 25 | SIK3 | 1.21891759 |
| 26 | MAPK12 | 1.19421889 |
| 27 | TRIM28 | 1.18586894 |
| 28 | CDK12 | 1.17921547 |
| 29 | MARK1 | 1.14679675 |
| 30 | RIPK4 | 1.12197515 |
| 31 | CAMK1D | 1.10474812 |
| 32 | BCR | 1.09626447 |
| 33 | NLK | 1.08441621 |
| 34 | MAP3K3 | 1.07957040 |
| 35 | PRKAA2 | 1.07735046 |
| 36 | MAP3K6 | 1.07338538 |
| 37 | BLK | 1.06626518 |
| 38 | RPS6KA4 | 1.06034372 |
| 39 | EPHB1 | 1.01998436 |
| 40 | MAP2K3 | 1.00511101 |
| 41 | BMPR2 | 0.98004522 |
| 42 | FGFR3 | 0.94976671 |
| 43 | MAP3K7 | 0.94960068 |
| 44 | RET | 0.94945040 |
| 45 | CAMK4 | 0.90527990 |
| 46 | ERN1 | 0.86745983 |
| 47 | TYK2 | 0.85739944 |
| 48 | PDK2 | 0.85386231 |
| 49 | PINK1 | 0.83612830 |
| 50 | PIK3CA | 0.83186939 |
| 51 | YES1 | 0.81224780 |
| 52 | CDK6 | 0.80559050 |
| 53 | SGK3 | 0.78559795 |
| 54 | NEK6 | 0.77694735 |
| 55 | CAMK1G | 0.77435617 |
| 56 | MAP3K13 | 0.77383315 |
| 57 | SGK2 | 0.75703592 |
| 58 | TRPM7 | 0.75596751 |
| 59 | PDGFRA | 0.71769901 |
| 60 | JAK2 | 0.70875633 |
| 61 | FGR | 0.70785145 |
| 62 | MST1R | 0.69969107 |
| 63 | CSK | 0.67927939 |
| 64 | MAP3K10 | 0.67346934 |
| 65 | MAP3K9 | 0.66811466 |
| 66 | MAP2K4 | 0.64953657 |
| 67 | MAP3K5 | 0.64883127 |
| 68 | MAP3K14 | 0.64870095 |
| 69 | MELK | 0.63878534 |
| 70 | MAP3K1 | 0.60766939 |
| 71 | KSR1 | 0.60500863 |
| 72 | RAF1 | 0.58005913 |
| 73 | MAPK7 | 0.57555706 |
| 74 | PKN2 | 0.55683760 |
| 75 | ICK | 0.55077719 |
| 76 | FER | 0.54380152 |
| 77 | RPS6KB1 | 0.52664936 |
| 78 | EIF2AK3 | 0.51436941 |
| 79 | INSRR | 0.50797118 |
| 80 | AKT2 | 0.48596881 |
| 81 | RIPK1 | 0.48159100 |
| 82 | EEF2K | 0.47509497 |
| 83 | DYRK1B | 0.47052945 |
| 84 | PTK2B | 0.46992189 |
| 85 | PRKD1 | 0.46836061 |
| 86 | MOS | 0.45124638 |
| 87 | ZAP70 | 0.45065601 |
| 88 | FGFR4 | 0.43602271 |
| 89 | TRIB3 | 0.40619962 |
| 90 | PDGFRB | 0.40481603 |
| 91 | STK10 | 0.40217951 |
| 92 | BTK | 0.39678829 |
| 93 | PRKAA1 | 0.39206966 |
| 94 | MAP2K7 | 0.39046498 |
| 95 | BRAF | 0.36652370 |
| 96 | CDC7 | 0.36392924 |
| 97 | MAPK11 | 0.36227938 |
| 98 | CAMK2B | 0.34794504 |
| 99 | ARAF | 0.33849098 |
| 100 | HCK | 0.32771259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.07456916 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.53342019 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.42073771 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.15937701 |
| 5 | Thyroid cancer_Homo sapiens_hsa05216 | 2.08413757 |
| 6 | Endometrial cancer_Homo sapiens_hsa05213 | 2.03082517 |
| 7 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.97046077 |
| 8 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.94884981 |
| 9 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.90866387 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.86621416 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.70095328 |
| 12 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.61760678 |
| 13 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.61409935 |
| 14 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.60818570 |
| 15 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.60090628 |
| 16 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.58346636 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.52783713 |
| 18 | Insulin resistance_Homo sapiens_hsa04931 | 1.42891027 |
| 19 | Prostate cancer_Homo sapiens_hsa05215 | 1.41338162 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.38023480 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.34674782 |
| 22 | Glioma_Homo sapiens_hsa05214 | 1.29477158 |
| 23 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.26072421 |
| 24 | Colorectal cancer_Homo sapiens_hsa05210 | 1.24401073 |
| 25 | Adherens junction_Homo sapiens_hsa04520 | 1.20688442 |
| 26 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.19299157 |
| 27 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.19195248 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17714590 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16679062 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15619943 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.14562990 |
| 32 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.06844036 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05895061 |
| 34 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.05010126 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.04473403 |
| 36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02484958 |
| 37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99906313 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.99901128 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 0.99863026 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99028078 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99027082 |
| 42 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.96881875 |
| 43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95954395 |
| 44 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.95228380 |
| 45 | Focal adhesion_Homo sapiens_hsa04510 | 0.93922140 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 0.91935235 |
| 47 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.90551744 |
| 48 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89437418 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89425885 |
| 50 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88495645 |
| 51 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87326767 |
| 52 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87171664 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87134599 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87058635 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85238567 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82965299 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82646294 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82336654 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80655387 |
| 60 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79085935 |
| 61 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.76337598 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74353516 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73239433 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72490695 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71188883 |
| 66 | Measles_Homo sapiens_hsa05162 | 0.70897342 |
| 67 | Melanoma_Homo sapiens_hsa05218 | 0.70724677 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69636150 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 0.69392190 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69194744 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68901910 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68184283 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.67873311 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67142396 |
| 75 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66490282 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65679659 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64280855 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63960313 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.62857249 |
| 80 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60992903 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60566875 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60218135 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.58686751 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.58651784 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58344503 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58071625 |
| 87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57341831 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.56869673 |
| 89 | Shigellosis_Homo sapiens_hsa05131 | 0.56095252 |
| 90 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.55872515 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55781655 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55544746 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53242333 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53053626 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51047314 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.48546037 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46116061 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44676397 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44616625 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.42427833 |

